# Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

> **NCT00045539** · PHASE2 · COMPLETED · sponsor: **New Approaches to Brain Tumor Therapy Consortium**

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** leucovorin calcium
- **DRUG:** methotrexate
- **DRUG:** thiotepa

## Key facts

- **NCT ID:** NCT00045539
- **Lead sponsor:** New Approaches to Brain Tumor Therapy Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045539, "Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00045539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*